Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 221,099 | 214,182 | 143,096 | 131,211 | 157,999 |
| Cost of Goods | 127,550 | 129,331 | 83,862 | 70,390 | 73,561 |
| Gross Profit | 93,549 | 84,851 | 59,234 | 60,821 | 84,438 |
| Operating Expenses | 66,540 | 67,129 | 66,944 | 60,063 | 59,498 |
| Operating Income | 27,559 | 18,053 | -6,848 | 1,148 | 25,501 |
| Interest Expense | 8,182 | 6,953 | 3,975 | 46 | 25 |
| Other Income | 41,955 | -15,648 | 118 | 548 | 378 |
| Pre-tax Income | 61,332 | -4,548 | -10,705 | 1,650 | 25,854 |
| Income Tax | 25,577 | -2,696 | -4,372 | 1,530 | 10,117 |
| Net Income Continuous | 35,755 | -1,852 | -6,333 | 120 | 15,737 |
| Net Income | $35,755 | $-1,852 | $-6,333 | $120 | $15,737 |
| EPS Basic Total Ops | 0.51 | -0.03 | -0.09 | 0.00 | 0.23 |
| EPS Basic Continuous Ops | 0.51 | -0.03 | -0.09 | 0.00 | 0.23 |
| EPS Diluted Total Ops | 0.49 | -0.03 | -0.09 | 0.00 | 0.22 |
| EPS Diluted Continuous Ops | 0.49 | -0.03 | -0.09 | 0.00 | 0.22 |
| EBITDA(a) | $46,437 | $37,397 | $3,594 | $10,623 | $33,749 |